Novonesis
373.00 DKK
-3.89 %
Less than 1K followers
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
-3.89 %
-3.69 %
-2.61 %
-8.53 %
-10.12 %
-12.71 %
+7.93 %
-15.86 %
+908.11 %
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
174.68B DKK
Turnover
486.92M DKK
Revenue
31.05B
EBIT %
19.64 %
P/E
39.96
Dividend yield-%
1.14 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.8
2026
Interim report Q2'26
All
Research
Press releases
ShowingAll content types
HCA - Novonesis Redflag Analyse
HCA Morgenbørs 05/05 - Fokus på regnskaber fra ISS, Novonesis, DFDS, Demant og Trifork.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools